Table 1. Pre-surgery (at enrollment) demographics of EndoQUEST participants.
| All Participants (N = 100) | |
|---|---|
| Age at surgery (years) | |
| Mean (SD) | 16.8 (2.3) |
| Median (Min-Max) | 16.0 (12–23) |
| Race, N(%) | |
| White | 94 (94.0) |
| Other/Unknown | 6 (6.0) |
| Ethnicity, N(%) | |
| Hispanic | 5 (5.0) |
| Non-Hispanic | 95 (95.0) |
| Hormone use before surgery, N(%)a | |
| No | 8 (8.0) |
| Yes | 92 (92.0) |
| Pain medication use before surgery, N(%)b | |
| No | 65 (64.0) |
| Yes | 35 (35.0) |
| Body Mass Index (kg/m2), N(%) | |
| Underweight | 0 (0) |
| Normal weight | 66 (66.0) |
| Overweight | 29 (29.0) |
| Obese | 5 (5.0) |
aHormone medications included combined estrogen/progestin contraceptives, progestin-only pills, norethindrone acetate, medroxyprogesterone acetate, GnRH agonists, and progesterone-containing intrauterine devices.
bRegular pain medication use was defined as ≥1 time/week over a period of ≥3 months. Examples of pain medications included acetaminophen, aspirin, ibuprofen, COX-2 inhibitors, narcotic analgesics, and muscle relaxants.